5:18 PM
 | 
May 16, 2014
 |  BC Extra  |  Financial News

Antibody company Kymab raises $40 million in series B

Kymab Ltd. (Cambridge, U.K.) raised $40 million in a series B round from the Bill & Melinda Gates Foundation, a new investor, and the Wellcome Trust, an existing investor. The investors split the round equally....

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >